SILK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SILK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Silk Road Medical's yield on cost for the quarter that ended in Dec. 2023 was 0.00.
The historical rank and industry rank for Silk Road Medical's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Medical Devices subindustry, Silk Road Medical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Silk Road Medical's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Silk Road Medical's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Silk Road Medical is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
Silk Road Medical (NAS:SILK) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of Silk Road Medical's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Chas Mckhann | director, officer: Chief Executive Officer | 1555 ADAMS DRIVE, C/O INTERSECT ENT, INC., MENLO PARK CA 94025 |
Marie L. Jones | officer: CAO and VP, Finance | 1213 INNSBRUCK DRIVE, SUNNYVALE CA 94089 |
Lucas W. Buchanan | officer: Chief Financial Officer | C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE, SUNNYVALE CA 94089 |
Kevin M Klemz | officer: EVP/Chief Legal Officer/Sec. | 9600 54TH AVENUE NORTH, SUITE 100, PLYMOUTH MN 55442 |
Andrew S. Davis | officer: Chief Commercial Officer | C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE, SUNNYVALE CA 94089 |
Erica J. Rogers | director, officer: President and CEO | C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE, SUNNYVALE CA 94089 |
Elizabeth H Weatherman | director | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
Richard Ruedy | officer: EVP Clin & Reg. Affairs and QA | C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE, SUNNYVALE CA 94089 |
Tony M. Chou | director | C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE, SUNNYVALE CA 94089 |
Tanisha Carino | director | C/O ALEXION PHARMACEUTICALS, INC., 121 SEAPORT BOULEVARD, BOSTON MA 02210 |
Kevin J. Ballinger | director | C/O BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234 |
Rick D Anderson | director | 3600 N CAPITAL OF TEXAS HWY, SUITE B180, AUSTIN TX 78746 |
Donald Zurbay | director | C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
Warburg Pincus Partners Gp Llc | 10 percent owner | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
Warburg Pincus & Co. | 10 percent owner | 450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147 |
From GuruFocus
By Marketwired • 10-16-2023
By Marketwired • 10-11-2023
By GuruFocus Research GuruFocus Editor • 12-15-2022
By PRNewswire • 10-17-2023
By sperokesalga sperokesalga • 04-26-2023
By Marketwired • 08-03-2023
By sperokesalga sperokesalga • 05-04-2023
By Marketwired • 10-10-2023
By sperokesalga sperokesalga • 05-09-2023
By sperokesalga sperokesalga • 04-18-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.